Optimal time for catheterization in NSTE-ACS patients with impaired renal function: insights from the ABOARD Study.

Optimal time for catheterization in NSTE-ACS patients with impaired renal function: insights from the ABOARD Study. Publié dans International Journal of Cardiology, le 10 septembre 2013. En savoir plus en consultant le site. Auteurs : Barthélémy O, Cayla G, Silvain J, O'Connor SA, Bellemain-Appaix A, Beygui F, Sideris G, Varenne O, Collet JP, Vicaut E, Montalescot G;…

Identification of poor response to P2Y12 inhibitors in ACS patients with a new ELISA-based vasodilator-associated stimulated phosphoprotein (VASP) phosphorylation assay.

Identification of poor response to P2Y12 inhibitors in ACS patients with a new ELISA-based vasodilator-associated stimulated phosphoprotein (VASP) phosphorylation assay. Publié dans Thrombosis and Haemostasis, le 08 août 2013. En savoir plus en consultant le site. Auteurs : Abtan J, Silvain J, Kerneis M, O'Connor SA, Barthélémy O, Vignalou JB, Beygui F, Brugier D, Collet JP, Montalescot…

Safety and efficacy of adjuvant glycoprotein IIb/IIIa inhibitors during primary percutaneous coronary intervention performed from the radial approach for acute ST segment elevation myocardial infarction.

Safety and efficacy of adjuvant glycoprotein IIb/IIIa inhibitors during primary percutaneous coronary intervention performed from the radial approach for acute ST segment elevation myocardial infarction. Publié dans American Journal of Cardiology, le 15 juin 2013. En savoir plus en consultant le site. Auteurs : Iqbal Z, Cohen M, Pollack C, Goldstein P, Zeymer U, Huber K, Barthelemy…